These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9502394)

  • 1. Urinary bladder carcinogenesis.
    Cohen SM
    Toxicol Pathol; 1998; 26(1):121-7. PubMed ID: 9502394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summation effect of N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazoly)formamide, N-2-fluoroenylacetamide, and 3,3'-dichlorobenzidine on urinary bladder carcinogenesis in rats.
    Tatematsu M; Miyata Y; Mizutani M; Hananouchi M; Hirose M
    Gan; 1977 Apr; 68(2):193-202. PubMed ID: 892293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenicity of uracil, a nongenotoxic chemical, in rats and mice and its rationale.
    Fukushima S; Tanaka H; Asakawa E; Kagawa M; Yamamoto A; Shirai T
    Cancer Res; 1992 Apr; 52(7):1675-80. PubMed ID: 1551098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and etiology of premalignant and malignant urothelial changes.
    Cohen SM; Shirai T; Steineck G
    Scand J Urol Nephrol Suppl; 2000; (205):105-15. PubMed ID: 11144890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraepithelial lesions of the urinary bladder with a discussion of the histogenesis of urothelial neoplasia.
    Amin MB; Young RH
    Semin Diagn Pathol; 1997 May; 14(2):84-97. PubMed ID: 9179970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kitahori Y; Konishi N; Shimoyama T; Hiasa Y
    Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The etiology of cancer of the bladder.
    Oyasu R; Hopp ML
    Surg Gynecol Obstet; 1974 Jan; 138(1):97-108. PubMed ID: 4587689
    [No Abstract]   [Full Text] [Related]  

  • 10. Current concepts of the aetiology, pathogenesis and pathology of bladder cancer.
    Friedell GH
    Urol Res; 1978; 6(4):179-82. PubMed ID: 369082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of bladder cancer.
    Friedell GH; Jacobs JB; Nagy GK; Cohen SM
    Am J Pathol; 1977 Nov; 89(2):431-42. PubMed ID: 920778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histogenesis of urinary bladder cancer induced in rats by bracken fern.
    Pamukcu AM; Ertürk E; Yalçiner S; Bryan GT
    Invest Urol; 1976 Nov; 14(3):213-8. PubMed ID: 992973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats.
    Tatematsu M; Fukushima S; Aoki T; Mera Y; Inoue T; Ito N
    Jpn J Cancer Res; 1987 Sep; 78(9):879-82. PubMed ID: 3117745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pathology of proliferative lesions of the urinary bladder.
    Cohen SM
    Toxicol Pathol; 2002; 30(6):663-71. PubMed ID: 12512866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A
    J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-track pathway of bladder carcinogenesis: practical implications.
    Spiess PE; Czerniak B
    Arch Pathol Lab Med; 2006 Jun; 130(6):844-52. PubMed ID: 16740038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cell proliferation data in modeling urinary bladder carcinogenesis.
    Cohen SM; Ellwein LB
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):111-3. PubMed ID: 8013397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.
    Tsuda H; Miyata Y; Murasaki G; Kinoshita H; Fukushima S
    Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292
    [No Abstract]   [Full Text] [Related]  

  • 19. Promoting effect of sodium o-phenylphenate and o-phenylphenol on two-stage urinary bladder carcinogenesis in rats.
    Fukushima S; Kurata Y; Shibata M; Ikawa E; Ito N
    Gan; 1983 Oct; 74(5):625-32. PubMed ID: 6642136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculi, precipitates and microcrystalluria associated with irritation and cell proliferation as a mechanism of urinary bladder carcinogenesis in rats and mice.
    Fukushima S; Murai T
    IARC Sci Publ; 1999; (147):159-74. PubMed ID: 10457916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.